Cargando…

Elevated doublecortin-like kinase 1 serum levels revert to baseline after therapy in early stage esophageal adenocarcinoma

BACKGROUND: Barrett’s esophagus (BE) and esophageal adenocarcinoma (EAC) incidence has been increasing in the United States for greater than 30 years. For the majority of EAC patients, treatment is limited and prognosis poor. Doublecortin like kinase-1 (DCLK1) is a cancer stem cell marker with eleva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Christman, Emily M., Chandrakesan, Parthasarathy, Weygant, Nathaniel, Maple, John T., Tierney, William M., Vega, Kenneth J., Houchen, Courtney W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408757/ https://www.ncbi.nlm.nih.gov/pubmed/30899515 http://dx.doi.org/10.1186/s40364-019-0157-z

Ejemplares similares

Ablation of Doublecortin-Like Kinase 1 in the Colonic Epithelium Exacerbates Dextran Sulfate Sodium-Induced Colitis
por: Qu, Dongfeng, et al.
Publicado: (2015)

Doublecortin-Like Kinase 1 Is Elevated Serologically in Pancreatic Ductal Adenocarcinoma and Widely Expressed on Circulating Tumor Cells
por: Qu, Dongfeng, et al.
Publicado: (2015)

Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1
por: Weygant, Nathaniel, et al.
Publicado: (2014)

Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism
por: Ali, Naushad, et al.
Publicado: (2013)

Correction: Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism
por: Ali, Naushad, et al.
Publicado: (2013)

Inflammatory and oncogenic roles of a tumor stem cell marker doublecortin-like kinase (DCLK1) in virus-induced chronic liver diseases
por: Ali, Naushad, et al.
Publicado: (2015)

Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment
por: Cao, Zhiyun, et al.
Publicado: (2020)

Doublecortin-like kinase 1 promotes hepatocyte clonogenicity and oncogenic programming via non-canonical β-catenin-dependent mechanism
por: Ali, Naushad, et al.
Publicado: (2020)

Epigenetic Landscape and Therapeutic Implication of Gene Isoforms of Doublecortin-Like Kinase 1 for Cancer Stem Cells
por: Moore, Landon L., et al.
Publicado: (2023)

Dclk1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition
por: Chandrakesan, Parthasarathy, et al.
Publicado: (2014)

Intestinal tuft cells regulate the ATM mediated DNA Damage response via Dclk1 dependent mechanism for crypt restitution following radiation injury
por: Chandrakesan, Parthasarathy, et al.
Publicado: (2016)

Dclk1, a tumor stem cell marker, regulates pro-survival signaling and self-renewal of intestinal tumor cells
por: Chandrakesan, Parthasarathy, et al.
Publicado: (2017)

Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments
por: Wu, Xiangyan, et al.
Publicado: (2020)

Dietary Pectin Increases Intestinal Crypt Stem Cell Survival following Radiation Injury
por: Sureban, Sripathi M., et al.
Publicado: (2015)

Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism
por: Sureban, Sripathi M., et al.
Publicado: (2015)

DCLK1 Regulates Pluripotency and Angiogenic Factors via microRNA-Dependent Mechanisms in Pancreatic Cancer
por: Sureban, Sripathi M., et al.
Publicado: (2013)

Dclk1(+) small intestinal epithelial tuft cells display the hallmarks of quiescence and self-renewal
por: Chandrakesan, Parthasarathy, et al.
Publicado: (2015)

DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma
por: Weygant, Nathaniel, et al.
Publicado: (2014)

DCLK1 Regulates Tumor Stemness and Cisplatin Resistance in Non-small Cell Lung Cancer via ABCD-Member-4
por: Panneerselvam, Janani, et al.
Publicado: (2020)

Sex-Associated Gene Expression Alterations Correlate With Esophageal Cancer Survival
por: Weygant, Nathaniel, et al.
Publicado: (2020)

Regulatory Roles of Dclk1 in Epithelial Mesenchymal Transition and Cancer Stem Cells
por: Chandrakesan, P, et al.
Publicado: (2016)

Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19
por: Undi, Ram Babu, et al.
Publicado: (2022)

Overexpression of DCLK1-AL Increases Tumor Cell Invasion, Drug Resistance, and KRAS Activation and Can Be Targeted to Inhibit Tumorigenesis in Pancreatic Cancer
por: Qu, Dongfeng, et al.
Publicado: (2019)

Discovery of a selective inhibitor of Doublecortin Like Kinase 1
por: Ferguson, Fleur M., et al.
Publicado: (2020)

Autoregulatory control of microtubule binding in doublecortin-like kinase 1
por: Agulto, Regina L, et al.
Publicado: (2021)

Inflammatory Mediators and Gut Microbial Toxins Drive Colon Tumorigenesis by IL-23 Dependent Mechanism
por: Panneerselvam, Janani, et al.
Publicado: (2021)

The evolving doublecortin (DCX) superfamily
por: Reiner, Orly, et al.
Publicado: (2006)

Doublecortin Mutation in an Adolescent Male
por: Zare, Isabelle, et al.
Publicado: (2019)

Doublecortin-like kinase enhances dendritic remodelling and negatively regulates synapse maturation
por: Shin, Euikyung, et al.
Publicado: (2013)

Doublecortin-like kinase 1 expression associates with breast cancer with neuroendocrine differentiation
por: Liu, Yu-Hong, et al.
Publicado: (2015)

Doublecortin-like kinase 1 compromises DNA repair and induces chromosomal instability
por: Lu, Yuxiong, et al.
Publicado: (2018)

Bufalin Inhibits Tumorigenesis, Stemness, and Epithelial–Mesenchymal Transition in Colorectal Cancer through a C-Kit/Slug Signaling Axis
por: Ding, Ling, et al.
Publicado: (2022)

Immunohistochemical study of doublecortin and nucleostemin in canine brain
por: De Nevi, E., et al.
Publicado: (2013)

Structural basis for small molecule targeting of Doublecortin Like Kinase 1 with DCLK1-IN-1
por: Patel, Onisha, et al.
Publicado: (2021)

Discovery and Development of a Novel mPGES-1/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases
por: Yarla, Nagendra Sastri, et al.
Publicado: (2020)

Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
por: Nishio, Kohei, et al.
Publicado: (2017)

Spatiotemporal Pattern of Doublecortin Expression in the Retina of the Sea Lamprey
por: Fernández-López, Blanca, et al.
Publicado: (2016)

Doublecortin-expressing cell types in temporal lobe epilepsy
por: Liu, Joan Y. W., et al.
Publicado: (2018)

Doublecortin in Oligodendrocyte Precursor Cells in the Adult Mouse Brain
por: Boulanger, Jenna J., et al.
Publicado: (2017)

Widespread Doublecortin Expression in the Cerebral Cortex of the Octodon degus
por: van Groen, Thomas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rmeenaqv5su76d6h7hvn5v4fb4